JP McHale And US Biologic Unveil LymeShield To Fight Lyme Disease Spike

In an innovative move to combat the rising threat of Lyme Disease and tick-borne diseases in Westchester, the Hudson Valley, and across the nation, JP McHale Pest Management has teamed up with US Biologic. This partnership marks the introduction of the LymeShield System, a pioneering approach in the fight against these diseases. The LymeShield System stands out as an Integrated Pest Management (IPM) program that utilizes a unique pellet to inoculate mice against Lyme Disease. This strategy is based on the understanding that mice free from infection cannot transmit the disease to ticks, thereby halting the spread of the disease further.

The product has received conditional approval from the USDA and is now accessible in New York State. Both JP McHale and US Biologic are dedicated to safeguarding communities through effective pest control solutions. This includes early detection of ticks and eliminating Lyme Disease with advanced pest control technologies. Jim McHale, president of JP McHale Pest Management, expressed enthusiasm about introducing LymeShield technology. He highlighted its alignment with the company’s mission to mitigate the threat of tickborne diseases in serviced areas. LymeShield is now available for use in homes, businesses, and public spaces, including parks in Westchester County.

LymeShield's launch plays a crucial role in JP McHale’s Integrative Pest Management strategies, which aim to minimize biocide use for pest control and elimination. The company has also seen significant success with its SMART Rodent Detection and Home Monitoring System. This system employs wireless technology to monitor pest activity digitally and provides real-time alerts without using harmful chemicals, ensuring safety for pets, children, and the environment.

LymeShield operates through timed application stations that distribute pellets to inoculate mice against Borrelia burgdorferi, the bacterium responsible for Lyme Disease in humans. These strategically placed stations have proven effective in delivering pellets to mice year-round. Integrative Pest Management techniques like these are vital in reducing Lyme Disease transmission risk, which remains the leading vector-borne disease in the U.S., affecting an estimated 476,000 people annually according to CDC projections.

US Biologic CEO Mason Kauffman praised JP McHale as a visionary company for its commitment to leveraging new technologies against the escalating spread of Lyme Disease. With New York being more endemic than most states, this partnership could mark a significant step forward in controlling the disease.

JP McHale Pest Management, LLC specializes in pest elimination through biological and environmentally sensitive methods. This includes organic solutions and advanced remote technology options for both residential and commercial properties. As a partner of Anticimex and a family-run business led by James P. McHale, Jr., a Cornell entomologist, JP McHale is recognized among the top 40 Pest Control companies nationwide according to PCT's annual ranking.

US Biologic aims to create a world free from endemic and pandemic diseases with solutions like the LymeShield System. For more information on these innovative approaches to pest management and disease prevention, interested parties can visit their respective websites.